YF479

Modify Date: 2024-02-04 11:48:13

Use of YF479

YF479, a novel HDAC inhibitor, displays more potent anti-tumor activity in vitro and in vivo compared with hydroxamic acid (SAHA).

Name	YF479

Description	YF479, a novel HDAC inhibitor, displays more potent anti-tumor activity in vitro and in vivo compared with hydroxamic acid (SAHA).
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> HDAC Signaling Pathways >> Epigenetics >> HDAC
References	[1]. Zhang T, et al. Antitumor action of a novel histone deacetylase inhibitor, YF479, in breast cancer. Neoplasia. 2014 Aug;16(8):665-77.

Molecular Formula	C₂₂H₂₇BrN₂O₅
Molecular Weight	479.36

Get all suppliers and price by the below link: